Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Cabel

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Oncogene|September 15, 2019
ERBB3 mutations in cancer: biological aspects, prevalence and therapeuticsNicolas Kiavue, Luc Cabel, Samia Melaabi, et al.
Journal for Immunotherapy of Cancer|April 22, 2017
Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patientsLuc Cabel, Elika Loir, Gwenaelle Gravis, et al.
Journal of Clinical Medicine|September 9, 2023
Clinical Utility of Pre-Therapeutic [18F]FDG PET/CT Imaging for Predicting Outcomes in Breast CancerSophia Najid, Romain-David Seban, Laurence Champion, et al.
Nature Reviews. Clinical Oncology|July 28, 2018
Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapyLuc Cabel, Charlotte Proudhon, Emanuela Romano, et al.
JCO Precision Oncology|February 1, 2022
Efficacy of Lorlatinib in Primary Crizotinib-Resistant Adult Neuroblastoma Harboring <i>ALK</i> Y1278S MutationAntoine Vasseur, Luc Cabel, Romain Geiss, et al.
Bulletin Du Cancer|May 28, 2016
[ESMO ECCO 2015: The highlights of immunotherapy and targeted therapies]Clément Bonnet, Guillaume Beinse, Luc Cabel, et al.
International Journal of Cancer|July 4, 2017
HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: A case reportLuc Cabel, François-Clément Bidard, Vincent Servois, et al.
Radiology|August 1, 2023
Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast CancersToulsie Ramtohul, Lounes Djerroudi, Emilie Lissavalid, et al.
International Journal of Radiation Oncology, Biology, Physics|June 17, 2025
Cardiac Outcomes Following Adjuvant Radiation Therapy in Triple-Negative Breast Cancer Patients With Prior Autoimmune MyocarditisPierre Loap, Assile El Fakih, Clara Helal, et al.
Frontiers in Oncology|October 5, 2020
Quantitative CT Extent of Lung Damage in COVID-19 Pneumonia Is an Independent Risk Factor for Inpatient Mortality in a Population of Cancer Patients: A Prospective StudyToulsie Ramtohul, Luc Cabel, Xavier Paoletti, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Oncogene|September 15, 2019
ERBB3 mutations in cancer: biological aspects, prevalence and therapeuticsNicolas Kiavue, Luc Cabel, Samia Melaabi, et al.
Journal for Immunotherapy of Cancer|April 22, 2017
Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patientsLuc Cabel, Elika Loir, Gwenaelle Gravis, et al.
Journal of Clinical Medicine|September 9, 2023
Clinical Utility of Pre-Therapeutic [18F]FDG PET/CT Imaging for Predicting Outcomes in Breast CancerSophia Najid, Romain-David Seban, Laurence Champion, et al.
Nature Reviews. Clinical Oncology|July 28, 2018
Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapyLuc Cabel, Charlotte Proudhon, Emanuela Romano, et al.
JCO Precision Oncology|February 1, 2022
Efficacy of Lorlatinib in Primary Crizotinib-Resistant Adult Neuroblastoma Harboring <i>ALK</i> Y1278S MutationAntoine Vasseur, Luc Cabel, Romain Geiss, et al.
Bulletin Du Cancer|May 28, 2016
[ESMO ECCO 2015: The highlights of immunotherapy and targeted therapies]Clément Bonnet, Guillaume Beinse, Luc Cabel, et al.
International Journal of Cancer|July 4, 2017
HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: A case reportLuc Cabel, François-Clément Bidard, Vincent Servois, et al.
Radiology|August 1, 2023
Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast CancersToulsie Ramtohul, Lounes Djerroudi, Emilie Lissavalid, et al.
International Journal of Radiation Oncology, Biology, Physics|June 17, 2025
Cardiac Outcomes Following Adjuvant Radiation Therapy in Triple-Negative Breast Cancer Patients With Prior Autoimmune MyocarditisPierre Loap, Assile El Fakih, Clara Helal, et al.
Frontiers in Oncology|October 5, 2020
Quantitative CT Extent of Lung Damage in COVID-19 Pneumonia Is an Independent Risk Factor for Inpatient Mortality in a Population of Cancer Patients: A Prospective StudyToulsie Ramtohul, Luc Cabel, Xavier Paoletti, et al.
Pageof 8